INFLUENCE OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR ON BIOCHEMICAL MARKERS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER COVID-19

被引：0
|
作者：
Sabirova, Guzal [1 ]
Uzokov, Jamol [2 ]
Usmonxudjaeva, Adiba [1 ]
Demin, Nikita [1 ]
Jumaeva, Gulruhsor [1 ]
机构：
[1] Tashkent Med Acad, Tashkent, Uzbekistan
[2] Republican Specialized Sci Pract Med Ctr Therapy, Cardiol, Tashkent, Uzbekistan
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P587
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Angiotensin Receptor-Neprilysin Inhibitor for Chronic Kidney Disease: Strategies for Renal Protection
    Hishida, Erika
    Nagata, Daisuke
    KIDNEY & BLOOD PRESSURE RESEARCH, 2024, 49 (01): : 916 - 932
  • [42] Angiotensin receptor-neprilysin inhibition improves peak oxygen consumption in reduced heart failure patients
    Catia Ferreira, C.
    Martinho, A. S.
    Almeida, J. P.
    Freitas, A. Z.
    Ferreira, J. A.
    Domingues, C.
    Milner, J.
    Costa, S.
    Franco, F.
    Vieira, H.
    Coutinho, R.
    Baptista, R.
    Goncalves, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 237 - 237
  • [43] Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
    Stolfo, Davide
    Benson, Lina
    Lindberg, Felix
    Dahlstrom, Ulf
    Kack, Oskar
    Sinagra, Gianfranco
    Lund, Lars H.
    Savarese, Gianluigi
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (10) : 2243 - 2257
  • [44] Outcomes of Angiotensin Receptor-Neprilysin Inhibitor Prescriptions for Patients with Heart Failure and Reduced Ejection Fraction in Real World Clinical Practice
    Malloy, Rhynn J.
    Smith, Katelyn V.
    Stern, Gretchen M.
    Desai, Akshay S.
    JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S28 - S28
  • [45] Clinical and Socioeconomic Determinants of Angiotensin Receptor-Neprilysin Inhibitor Prescription at Hospital Discharge in Patients With Heart Failure With Reduced Ejection Fraction
    Tran, Jeffrey S.
    Loveland, Macklin G.
    Alamer, Ahmad
    Pina, Ileana L.
    Sweitzer, Nancy K.
    CIRCULATION-HEART FAILURE, 2022, 15 (11) : E009395
  • [46] Early initiation of angiotensin receptor-neprilysin inhibitor improves heart failure outcome, natriuretic peptides and ejection fraction in patients with a recent hospitalisation with heart failure
    James, A. B.
    Williams, R. A.
    Vaughan, S.
    Ashton, M.
    Wong, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 380 - 380
  • [47] Six months clinical and echocardiographic outcome of angiotensin receptor-neprilysin inhibitor therapy in heart failure patients with reduced ejection fraction
    Alnims, M. Mohammed
    Magdy, Abdelhamid
    Meguid, M. Abdel
    Ahmed, Shehata
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 82 - 83
  • [48] Efficacy of Angiotensin Receptor-Neprilysin Inhibitor and Its Renal Outcome in Heart Failure Patients: A Systematic Review of Randomized Clinical Trials
    Almansouri, Naiela E.
    Bakkannavar, Saloni
    Faheem, Youmna
    Jaiswal, Amisha
    Shergill, Kainaat
    Boppana, Kusalik
    Nath, Tuheen Sankar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [49] Angiotensin Receptor-Neprilysin Inhibitor Therapy Reverses Pulmonary Hypertension in End-Stage Heart Failure Patients Awaiting Transplantation
    Zern, Emily K.
    Cheng, Susan
    Wolfson, Aaron M.
    Hamilton, Michele A.
    Zile, Michael R.
    Solomon, Scott D.
    Kittleson, Michelle M.
    CIRCULATION-HEART FAILURE, 2020, 13 (02) : E006696
  • [50] Angiotensin receptor-neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime
    Arcudi, Alessandra
    Di Francesco, Marco
    Rodolico, Daniele
    D'Amario, Domenico
    ESC HEART FAILURE, 2022, 9 (05): : 3639 - 3642
12345